Skip to main content
Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
27.02
-0.10 (-0.37%)
At close: Mar 9, 2026, 4:00 PM EDT
27.07
+0.05 (0.19%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Castle Biosciences Revenue

In the year 2025, Castle Biosciences had annual revenue of $344.23M with 3.66% growth. Castle Biosciences had revenue of $87.01M in the quarter ending December 31, 2025, with 0.81% growth.

Revenue (ttm)
$344.23M
Revenue Growth
+3.66%
P/S Ratio
2.33
Revenue / Employee
$389,840
Employees
883
Market Cap
803.34M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025344.23M12.16M3.66%
Dec 31, 2024332.07M112.28M51.09%
Dec 31, 2023219.79M82.75M60.38%
Dec 31, 2022137.04M42.95M45.65%
Dec 31, 202194.09M31.44M50.18%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Neogen 880.32M
Myriad Genetics 824.50M
NeoGenomics 727.33M
OPKO Health 606.88M
Veracyte 517.15M
GeneDx Holdings 427.54M
CareDx 379.81M
Fulgent Genetics 322.67M
Revenue Rankings

CSTL News

More News